VIEWRAY

viewray-logo

ViewRay develops advanced radiation therapy technology for the treatment of cancer. It designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delive... red. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s increased target accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who would not previously have been considered radiation therapy candidates. ViewRay believes MRIdian will significantly improve the safety and efficacy of radiation therapy, leading to improved patient outcomes with reduced side effects from off-target radiation delivery. The company was incorporated in 2004 and is based in Cleveland, Ohio.

#SimilarOrganizations #People #Financial #Event #Website #More

VIEWRAY

Social Links:

Industry:
Biotechnology Health Care Manufacturing Medical Device

Founded:
2004-01-01

Address:
Oakwood, Ohio, United States

Country:
United States

Website Url:
http://www.viewray.com

Total Employee:
251+

Status:
Active

Contact:
440-703-3210

Email Addresses:
[email protected]

Total Funding:
877.79 M USD

Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content IPv6 ReCAPTCHA V2 Amazon Virginia Region Amazon S3 CDN AWS Global Accelerator Lorem Ipsum ASP.NET Ajax Akamai Hosted


Similar Organizations

acceleron-pharma-logo

Acceleron Pharma

Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.

acutus-medical-logo

Acutus Medical

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

bolt-threads-logo

Bolt Threads

Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.

cvrx-logo

CVRx

CVRx is a medical device company developing implantable technology for the treatment of high blood pressure.

establishment-labs-logo

Establishment Labs

Establishment Labs, the next generation breast aesthetics company,

hydrafacial-logo

HydraFacial

HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.

neuropace-logo

NeuroPace

NeuroPace develops and markets implantable devices for the treatment of neurological disorders.

surmodics-logo

SurModics

SurModics provides a surface modification and in vitro diagnostic technologies to the healthcare industry.

vaxart-logo

Vaxart

Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.


Current Advisors List

josh-bilenker_image

Josh Bilenker Board of Directors @ ViewRay
Board_member
2008-01-01

brian-roberts_image

Brian Roberts Audit Chair / Member Board of Directors @ ViewRay
Board_member
2015-12-01

Current Employees Featured

james-f-dempsey_image

James F. Dempsey
James F. Dempsey Chief Scientific Officer and Founder @ ViewRay
Chief Scientific Officer and Founder
2004-03-01

virgil-lott_image

Virgil Lott
Virgil Lott VP Global Customer Support @ ViewRay
VP Global Customer Support
2018-06-01

steve-annen_image

Steve Annen
Steve Annen Vice President, Product Marketing @ ViewRay
Vice President, Product Marketing
2019-03-01

stephen-j-strunk_image

Stephen J. Strunk
Stephen J. Strunk Vice President @ ViewRay
Vice President

bill-burke_image

Bill Burke
Bill Burke Chief Financial Officer @ ViewRay
Chief Financial Officer
2023-01-01

not_available_image

Zach Stassen
Zach Stassen Chief Financial Officer @ ViewRay
Chief Financial Officer
2020-05-01

chris-a-raanes_image

Chris A. Raanes
Chris A. Raanes President and CEO @ ViewRay
President and CEO

Founder


james-f-dempsey_image

James F. Dempsey

richard-r-allen_image

Richard R. Allen

Stock Details


Company's stock symbol is NASDAQ:VRAY

Investors List

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - ViewRay

midcap-financial_image

MidCap Financial

MidCap Financial investment in Post-IPO Debt - ViewRay

elekta-ab_image

Elekta

Elekta investment in Post-IPO Equity - ViewRay

armentum-partners_image

Armentum Partners

Armentum Partners investment in Debt Financing - ViewRay

acuta-capital-partners_image

Acuta Capital Partners

Acuta Capital Partners investment in Post-IPO Equity - ViewRay

puissance-capital_image

Puissance Capital

Puissance Capital investment in Post-IPO Equity - ViewRay

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - ViewRay

kearny-venture-partners_image

Kearny Venture Partners

Kearny Venture Partners investment in Post-IPO Equity - ViewRay

xeraya-capital_image

Xeraya Capital

Xeraya Capital investment in Post-IPO Equity - ViewRay

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - ViewRay

Official Site Inspections

http://www.viewray.com Semrush global rank: 8.58 M Semrush visits lastest month: 509

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "ViewRay"

ViewRay, Inc. - Investor Relations

Jun 13, 2023 · ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients …See details»

The Collapse of ViewRay - Radiology Oncology Systems

Oct 13, 2023 · ViewRay’s MRIdian was the world’s first radiation therapy system to integrated diagnostic quality MRI. ViewRay’s journey to become a staple in the world of radiation oncology struggled from the onset.See details»

ViewRay Company Profile - Office Locations, Competitors ... - Craft

Aug 19, 2024 · ViewRay is a company that designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system. Its solution integrates MRI technology, radiation …See details»

ViewRay - Crunchbase Company Profile & Funding

ViewRay develops advanced radiation therapy technology for the treatment of cancer. It designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system that can image and treat cancer patients simultaneously.See details»

ViewRay Company Profile 2024: Stock Performance & Earnings

ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures, and markets radiation therapy systems that provide real-time imaging during radiation …See details»

ViewRay, Inc. - AnnualReports.com

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique …See details»

ViewRay, Inc. Company Profile | Oakwood Village, OH

Find company research, competitor information, contact details & financial data for ViewRay, Inc. of Oakwood Village, OH. Get the latest business insights from Dun & Bradstreet.See details»

ViewRay, Inc. - LinkedIn

ViewRay®, Inc. (NASDAQ:VRAY) shifts the paradigm in cancer treatment with the MRIdian® MRI-guided adaptive radiotherapy system.See details»

ViewRay, Inc. - Governance - Executive Management

At ViewRay, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by …See details»

ViewRay, Inc.: Culture - LinkedIn

ViewRay®, Inc. (NASDAQ:VRAY) shifts the paradigm in cancer treatment with the MRIdian® MRI-guided adaptive radiotherapy system. ViewRay, Inc. | 24,548 followers on LinkedIn.See details»

ViewRay, Inc. - ViewRay Announces Preliminary Fourth Quarter …

DENVER, Jan. 9, 2023 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended …See details»

Open Letter to ViewRay Customers From Krishnan Suthanthiran, …

Oct 13, 2023 · Krishnan Suthanthiran offers a solution for continued support and service to ViewRay customers.See details»

ViewRay's Leadership Team Team - Team members and org chart

The leadership team at ViewRay has a history of experience in various fields including academia, business, and medicine.See details»

ViewRay - Funding, Financials, Valuation & Investors - Crunchbase

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.See details»

ViewRay CEO and Key Executive Team | Craft.co

ViewRay's President, Chief Executive Officer & Director is Scott Drake. Other executives include Paul Ziegler, Executive Vice President and Chief Commercial Officer; James F. Dempsey, …See details»

ViewRay, Inc: Revolutionizing Radiation Therapy with Innovative ...

Jan 7, 2022 · ViewRay is a leading innovator in MRI-guided radiation therapy and aims to “Conquer cancer by re-envisioning technology.” IndustryWired has featured Scott Drake, CEO …See details»

ViewRay Announces Primary Endpoint Outcome from First …

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging …See details»

Working at ViewRay - Glassdoor

ViewRay, Inc (NASDAQ: VRAY), A New Kind of Medical Technology Company, was founded in 2004 on the belief that enhanced real-time visualization combined with on-line adapting and …See details»

ViewRay, Inc. - Governance - Committee Composition

At ViewRay, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by …See details»

ViewRay Climbing A Steep Hill As It Tries To Disrupt The Radiation ...

Jan 7, 2020 · Small-cap rad-onc company ViewRay (VRAY) certainly doesn't lack for ambition, as it is trying to disrupt the $5 billion radiation oncology equipment market with its MRI-guided …See details»

linkstock.net © 2022. All rights reserved